- Home
- PANL vs ATYR Comparison
PANL vs ATYR Comparison
Compare PANL & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- ATYR
- Stock Information
- Founded
- PANL 1996
- ATYR 2005
- Country
- PANL United States
- ATYR United States
- Employees
- PANL 651
- ATYR N/A
- Industry
- PANL Marine Transportation
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PANL Consumer Discretionary
- ATYR Health Care
- Exchange
- PANL Nasdaq
- ATYR Nasdaq
- Market Cap
- PANL 357.3M
- ATYR 330.7M
- IPO Year
- PANL N/A
- ATYR 2015
- Fundamental
- Price
- PANL $5.49
- ATYR $3.70
- Analyst Decision
- PANL Strong Buy
- ATYR Strong Buy
- Analyst Count
- PANL 1
- ATYR 6
- Target Price
- PANL N/A
- ATYR $18.60
- AVG Volume (30 Days)
- PANL 238.2K
- ATYR 1.9M
- Earning Date
- PANL 03-13-2025
- ATYR 03-13-2025
- Dividend Yield
- PANL 7.26%
- ATYR N/A
- EPS Growth
- PANL 8.62
- ATYR N/A
- EPS
- PANL 0.63
- ATYR N/A
- Revenue
- PANL $536,536,246.00
- ATYR $235,000.00
- Revenue This Year
- PANL $4.27
- ATYR $1,387.23
- Revenue Next Year
- PANL $17.15
- ATYR $873.22
- P/E Ratio
- PANL $8.75
- ATYR N/A
- Revenue Growth
- PANL 7.46
- ATYR N/A
- 52 Week Low
- PANL $4.69
- ATYR $1.42
- 52 Week High
- PANL $8.32
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- PANL 60.25
- ATYR 54.37
- Support Level
- PANL $5.34
- ATYR $2.98
- Resistance Level
- PANL $5.69
- ATYR $4.32
- Average True Range (ATR)
- PANL 0.19
- ATYR 0.39
- MACD
- PANL 0.08
- ATYR 0.06
- Stochastic Oscillator
- PANL 81.00
- ATYR 72.14
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.